The Boston Examiner
SEE OTHER BRANDS

The most trusted news from Massachusetts

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on August 14, 2025

Rony Jabour Leads Workplace Emergency Preparedness Keynote in Boston During Safe + Sound Week

Rony Jabour Leads Workplace Emergency Preparedness Keynote in Boston During Safe + Sound Week

Harvard-trained safety leader Rony Jabour delivers keynote in Boston during OSHA’s Safe + Sound Week on workplace emergency preparedness. BOSTON, MA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- Rony Jabour, a renowned occupational safety leader …

Simply Dental Management Surpasses 50,000 Smiles—and This Is Just the Beginning

Simply Dental Management Surpasses 50,000 Smiles—and This Is Just the Beginning

Celebrating decades of trusted, multi-generational care across 37 New England practices. HOPKINTON, MA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- Simply Dental Management (SDM) is proud to announce a significant milestone: more than 50,000 …

Massachusetts Residents May Qualify for No-Cost Energy Assessment and Upgrades Through Mass Save®

Massachusetts Residents May Qualify for No-Cost Energy Assessment and Upgrades Through Mass Save®

United Better Homes helps connect homeowners with energy-saving improvements across the state. ATTLEBORO, MA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- Homeowners across Massachusetts may be eligible for no-cost energy upgrades through the …

New Music Alert The Attic from Multi Talented American Artist Sam Welch

New Music Alert The Attic from Multi Talented American Artist Sam Welch

Track Title: The Attic Genre: Pop / Alternative Launch Date: Out Now ISRC Code: QZNWY2598328 BOSTON, MA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- Passionate about bridging the often solitary world of depression and emotional dysregulation …

Celebrating Over a Decade of Leadership Excellence from Harvard Square

Celebrating Over a Decade of Leadership Excellence from Harvard Square

Leaders Excellence Announces Program Updates to the Executive Mini-MBA℠ CAMBRIDGE, MA, UNITED STATES, August 14, 2025 /⁨EINPresswire.com⁩/ -- Today marks a special milestone for Leaders Excellence: the 11th anniversary of its official incorporation in …

Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights

PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-year Invivyd’s target of near-term profitability (1H 2025) was not met but remains possible with the upcoming respiratory virus season …

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19

Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, double-blind, placebo-controlled trial with a primary endpoint of reduction in symptomatic COVID-19, resembling …

Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results

Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results

FDA confirms requirement for confirmatory study of roluperidone for the treatment of negative symptoms in schizophrenia Evaluation of strategic alternatives BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a …

Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

–  Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with preliminary data in second half of 2025 and first half of 2026 –  Phase 1/ …

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

Presented positive translational data from SYNGAP1-related disorders program showcasing efficacy in a humanized SYNGAP mouse model and increased protein in non-human primates at the 28th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting …

Industry 4.0 Market to Hit $1.6 Trillion Globally by 2030

Industry 4.0 Market to Hit $1.6 Trillion Globally by 2030

Boston, Aug. 14, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Industry 4.0 Technologies: Global Market Through 2030” is projected to increase from $655.2 billion in 2025 to reach $1.6 trillion by 2030, at a compound annual …

Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

BOSTON and LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads for the treatment of cancer, today announced that it will …

Imprivata Patient Access Under Construction in Epic Toolbox for Identity Verification in MyChart

Imprivata Patient Access Under Construction in Epic Toolbox for Identity Verification in MyChart

WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today announced that Imprivata Patient Access is now under construction in Epic Toolbox in …

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, announced today that it has …

Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Presented positive results from the phase 3 randomized, placebo-controlled clinical trial of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer, during an oral presentation at the 2025 Annual Meeting of the American Society of Clinical …

BCC Research Forecasts Steady 4.6% CAGR for Blood Platelet Market Through 2030

BCC Research Forecasts Steady 4.6% CAGR for Blood Platelet Market Through 2030

Boston, Aug. 14, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Blood Platelet Market”  is expected to grow from $3.2 billion in 2025 to $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% …

Cerence Audio AI Integrates with HARMAN AudioworX to Enhance In-Car Experiences

Cerence Audio AI Integrates with HARMAN AudioworX to Enhance In-Car Experiences

BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced the integration of its industry-leading Audio AI suite into HARMAN’s …

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Achieves record number of ReWalk systems placed for Medicare beneficiaries since fee schedule established Third consecutive quarter of U.S. ReWalk pipeline growth with over 130 qualified leads in process Appoints new CEO and CFO to spearhead strategic …

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results

Announced updated Phase 2 data at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, demonstrating deep and durable responses and a meaningfully differentiated safety and tolerability profile for an anti-CTLA-4 combination therapy On track …

AMG Appoints Marcy Engel to its Board of Directors

AMG Appoints Marcy Engel to its Board of Directors

Dwight D. Churchill to Retire from Board of Directors Following 15-Year Service WEST PALM BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions